Adipose Triglyceride Lipase Antibody (YA637),MedChemexpress,HY-P80533
Adipose Triglyceride Lipase Antibody (YA637) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Adipose Triglyceride Lipase.
Host
Rabbit
Reactivity
Human,Mouse,Rat
Application
WB
Conjugate
Non-conjugated
Platform ID
BAB124156453
Suppliers
(1)Biomedical Life sciences
Plot No.A-2811121/A&B/3.IP NACHARAM. ALA NACHARAM, Road N0-15, Hyderabad Medchal Malkajgiri, Telangana-500076

MedChemexpress
Master of Bioactive Molecules
Contact
Tel: 609-228-6898
Fax: 609-228-5909
Email:
Product Specifications
Scientific Background
Synonyms
Specifications
NameAdipose Triglyceride Lipase Antibody (YA637)
Cat. No.HY-P80533
Accession NumberQ96AD5
Gene ID (Entrez)57104
HostRabbit
RRIDAB_3102122
IsotypeIgG
SensitivityEndogenous
ReactivityHuman,Mouse,Rat
ConjugationNon-conjugated
ApplicationWB
Working DilutionsWB: 1:500-1:1000
ClonalityRecombinant,Monoclonal
Clone NumberYA637
Molecular WeightPredicted band size: 55 kDa; Observed band size: 55 kDa
ImmunogenSynthetic peptide corresponding to Human Adipose Triglyceride Lipase.The exact sequence is proprietary to MCE.
Purityaffinity purified
Appearance/FormLiquid
ShippingShipping with blue ice.
FormulationSupplied in 50 mM Tris-Glycine (pH 7.4), 0.15 M NaCl, 40% Glycerol and 0.05% BSA. Preservative: 0.01% Sodium azide
StorageStored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.
Regulatory StatusResearch Use Only
Scientific Background
Adipose Triglyceride Lipase: This gene encodes an enzyme which catalyzes the first step in the hydrolysis of triglycerides in adipose tissue. Mutations in this gene are associated with neutral lipid storage disease with myopathy. [provided by RefSeq, Jul 2010]
Synonyms
ATGL; Desnutrin; plpl; plpl2; Pnpla2; TTS 2.2; TTS2; TTS2.2; ZETA
Category Paths
- Products>Primary Antibodies>Monoclonal Antibodies
- Products>Primary Antibodies>Recombinant Antibodies
Request a product
Please provide the required information below so that we can quickly source your products.
